Heilmann H D
Int J Clin Pharmacol Res. 1987;7(3):233-7.
Three hundred and eighty protocols of a multicentre study of ticarcillin plus clavulanic acid were evaluated. Patients with a multitude of severe infections were treated. Therapy with the drug combination was successful in 89% of the cases. The drug was tolerated very well. No severe adverse reactions were attributable to the test drug.
对380份替卡西林加克拉维酸多中心研究的方案进行了评估。治疗了患有多种严重感染的患者。该药物组合治疗在89%的病例中取得成功。该药物耐受性非常好。没有严重不良反应可归因于受试药物。